Clinical trial
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
NCT00231023 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00231023 |
|---|---|
| Title | Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema |
| Official title | Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Peribulbar Triamcinolone Acetonide |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Oct 3, 2005 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: